Teachers Now Prioritized for COVID-19 Vaccinations: What They Need to Know

Educators are now a priority for COVID-19 vaccinations, with plans to have all people who work…

Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical’s Razuprotafib in I-SPY COVID Trial

Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with…

Agilent to buy NGS-based precision oncology solutions company, Resolution Bioscience for 550 million

Agilent Technologies Inc., announced it has entered into a definitive agreement to acquire Resolution Bioscience Inc.,…

Telehealth Claim Lines Increase 2,817 Percent Nationally When Comparing December 2019 to December 2020

Telehealth claim lines1 increased 2,817 percent nationally from December 2019 to December 2020, rising from 0.22 percent of medical claim…

Arc Health Acquires Like-Minded Pinnacle Emergency Medical Group

A strategic partnership has been finalized between two mission-oriented medical staffing companies to expand high-quality medical…

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine…

American Pharmacists Association Comment on Authorization of Janssen Vaccine: We are Ready to Continue this Work

 Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists…

Goli Nutrition Pledges to Honor World NGO Day with 10x Donation to Vitamin Angels

 Goli Nutrition, creators of the world’s first Apple Cider Vinegar gummy and the world’s most powerful Ashwagandha…

Honeywell Expands Popular Ultraviolet Treatment Product Line To Serve New Transportation Segments

Expanding on its popular UV Treatment System for airliners, Honeywell has debuted a new, smaller version…

ESSA Pharma to Present at Upcoming March Investor Conferences

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel…